Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-22-000258
Filing Date
2022-01-13
Accepted
2022-01-13 16:01:44
Documents
4
Effectiveness Date
2022-01-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 sonoma_s8.htm S-8 63311
2 OPINION AND CONSENT OF BURNS & LEVINSON LLP sonoma_ex0501.htm EX-5.1 6545
3 CONSENT OF MARCUM LLP sonoma_ex2301.htm EX-23.1 2165
4 GRAPHIC image_003.jpg GRAPHIC 3733
  Complete submission text file 0001683168-22-000258.txt   78393
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-262144 | Film No.: 22529073
SIC: 2834 Pharmaceutical Preparations